Answers are grounded in this paper and cite their sources.
Background. Treatment of fibromyalgia syndrome (FMS) remains a clinical challenge. Pain, somatic and cognitive symptoms may be due to neurosensitization involving CNS-activated autonomic and musculoskeletal reactions, associated with EEG abnormalities that may respond to brainwave-based stimulation biofeedback. This study's objective was to examine the efficacy and safety of a novel EEG neurobiofeedback treatment, the Flexyx Neurotherapy System (FNS), and electrophysiological responses in persons with fibromyalgia.
No takes yet. Share an insight, caveat, or question.
Kravitz et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: